[1] 刘浩, 李忠廉, 尚海涛, 等.经皮肝胆囊穿刺与经皮肝胆管穿刺引流对低位恶性梗阻性黄疸患者术前减黄的疗效[J].中华肝胆外科杂志, 2017, 23(12):851. doi: 10.3760/cma.j.issn.1007-8118.2017.12.017
[2] 陈伟伟, 黄坤, 刘锐, 等.经皮肝穿刺胆管引流术联合胆道支架植入术治疗高位恶性梗阻性黄疸的效果及预后影响因素分析[J].临床肝胆病杂志, 2019, 35(3):559. doi: 10.3969/j.issn.1001-5256.2019.03.021
[3] CASADEIGARDINI A, SCARPI E, FALOPPI L, et al.Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib[J].Oncotarget, 2016, 7:67142.
[4] PASSARDI A, SCARPI E, CAVANNA L, et al.Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer[J].Oncotarget, 2016, 7:33210.
[5] HUANG L, LIU S, LEI Y, et al.Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection[J].Oncotarget, 2016, 7:44185.
[6] HONG X, CUI B, WANG M, et al.Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer[J].Tohoku J Exp Med, 2015, 236:297. doi: 10.1620/tjem.236.297
[7] 范恒伟, 刘会春, 李宗狂, 等.经PTCD途径胆道金属支架置入术治疗恶性梗阻性黄疸137例临床疗效分析[J].肝胆外科杂志, 2013, 21(2):94. doi: 10.3969/j.issn.1006-4761.2013.02.005
[8] 马海艳.经内镜逆行胰胆管造影支架置入对老年恶性梗阻性黄疸患者的临床疗效和对肝功能及免疫功能的影响[J].中国内镜杂志, 2017, 23(8):55.
[9] 胡红锋, 陈方志, 郭绿云, 等.PTCD途径胆道金属支架置入术治疗恶性梗阻性黄疸疗效分析[J].肝胆胰外科杂志, 2019, 31(5):314.
[10] 胡小四, 庞青, 刘会春, 等.经皮胆道支架联合导管载入式125I粒子治疗局部进展期肝外胆管癌的疗效评价与预后因素分析[J].介入放射学杂志, 2019, 28(4):369. doi: 10.3969/j.issn.1008-794X.2019.04.015
[11] 王强, 赵丽莎, 柯要军, 等.经皮肝穿刺胆管引流术治疗恶性梗阻性黄疸近期效果观察及影响因素分析[J].解放军医药杂志, 2016(2):55. doi: 10.3969/j.issn.2095-140X.2016.02.014
[12] TEMPLETON AJ, ACE O, MCNAMARA MG, et al.Prognostic role of platelet to lymphocyte ratio in solid tumors:a systematic review and meta-analysis[J].Cancer Epidemiol Biomarkers Prev, 2014, 23(7):1204. doi: 10.1158/1055-9965.EPI-14-0146
[13] 陈刚, 焦作义, 罗长江, 等.恶性梗阻性黄疸患者经皮经肝胆管引流术后营养支持方式与免疫功能恢复的关系[J].中华肝胆外科杂志, 2014, 20(5):355. doi: 10.3760/cma.j.issn.1007-8118.2014.05.010
[14] JIN H, PANG Q, LIU H.Prognostic value of inflammation-based markers in patients with recurrent malignant obstructive jaundice treated by reimplantation of biliary metal stents:A retrospective observational study[J].Medicine (Baltimore), 2017, 96(3):e5895. doi: 10.1097/MD.0000000000005895
[15] 宋勇, 秦高平, 杜立学, 等.胆道支架联合PTCD对恶性梗阻性黄疸患者肝功能与生活质量的影响研究[J].肝胆外科杂志, 2017, 25(2):118. doi: 10.3969/j.issn.1006-4761.2017.02.010
[16] 金浩, 刘会春, 李宗狂, 等.再次经皮经肝胆道支架置入治疗恶性梗阻性黄疸[J].中国微创外科杂志, 2017, 17(11):986. doi: 10.3969/j.issn.1009-6604.2017.11.007
[17] WILCOX CM, PHADNIS M, VARADARAJULU S.Biliary stent placement is associated with post-ERCP pancreatitis[J].GastrointestEndosc, 2010, 72(3):546.
[18] 徐川, 施海彬, 刘圣, 等.低位恶性梗阻性黄疸242例介入引流治疗的预后分析[J].介入放射学杂志, 2013, 22(2):133. doi: 10.3969/j.issn.1008-794X.2013.02.011